Inventor
Wei Wang
Inventor
Princeton, NJ, US
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds37%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
A61KPreparations for medical, dental or toiletry purposes21%
C07KPeptides7%
Y02PClimate change mitigation technologies in the production or processing of goods5%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology2%
H04LTransmission of digital information, e.g. telegraphic communication2%
PatentTitleYear
11,082,341Data processing202110,851,098Azole amides and amines as alpha v integrin inhibitors202010,793,543Selective C-KIT kinase inhibitor202010,669,238Irreversible bruton's tyrosine kinase inhibitor202010,472,355Cancer treatment utilizing SP-141 to bind with MDM2 and act as an inhibitor of MDM2 expression201910,266,535Inhibitor of FLT3 kinase and use thereof20199,974,778Substituted pyridinones as MGAT2 inhibitors20188,728,980'Peptide microarray and method of use'20148,658,131'Compounds comprising 4-benzoylpiperidine as a sigma-1-selective ligand'20148,415,386'Azolopyrrolone melanin concentrating hormone receptor-1 antagonists'20138,361,967'Beta sheet inhibiting peptides for preventing and/or treating Alzheimer\'s Disease'20137,951,793'Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method'20117,521,557'Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods'20097,452,907'Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method'20087,378,494'Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonist peptide'20087,323,570'Farnesyltransferase inhibitors'20087,279,485'Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method'20077,211,595'Farnesyltransferase inhibitors'20077,105,556'Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method'20065,945,431'Cytomegalovirus inhibiting compounds'19995,837,868'Process for preparation of chiral 3-amino-pyrrolidine and analogous bicyclic compounds'19985,726,182'Quinolizinone type compounds'19985,703,244'Process for preparation of chiral 3-amino-pyrrolidine and analogous bicyclic compounds'19975,693,813'Process for preparation of 4H-4-oxo-quinolizine-3-carboxylic acid'19975,599,816'Quinolizinone type compounds'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2008Patents assigned to ABBOTT LAB (7)· patent assignee history
1997–2007Based in Grayslake, IL, US· patent location history
1997–1998Based in Park City, IL, US· patent location history
2006–2020Patents assigned to BRISTOL MYERS SQUIBB CO (8)· patent assignee history
2006–2020Based in Princeton, NJ, US· patent location history
2013–2014Patents assigned to WANG WEI (3)· patent assignee history
2013Patents assigned to AHMAD SALEEM (1)· patent assignee history
2019–2020Patents assigned to HEFEI INST PHYSICAL SCI CAS (2)· patent assignee history
2019–2020Based in Anhui, CN· patent location history
2021Based in Beijing, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 8 | 2006–2020 |
| ABBOTT LAB | 7 | 1997–2008 |
| WANG WEIself | 3 | 2013–2014 |
| HEFEI INST PHYSICAL SCI CAS | 2 | 2019–2020 |
| AHMAD SALEEM | 1 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Princeton, New Jersey, US | 8 | 2006–2020 |
| Grayslake, Illinois, US | 4 | 1997–2007 |
| Anhui, CN | 3 | 2019–2020 |
| Park City, Illinois, US | 2 | 1997–1998 |
| Beijing, CN | 1 | 2021 |